Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Free Cash Flow (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Free Cash Flow for 16 consecutive years, with $279316.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow rose 455.41% year-over-year to $279316.0, compared with a TTM value of -$221530.0 through Oct 2025, up 69.5%, and an annual FY2025 reading of -$221530.0, up 69.5% over the prior year.
  • Free Cash Flow was $279316.0 for Q4 2025 at Pharma-Bio Serv, up from $234488.0 in the prior quarter.
  • Across five years, Free Cash Flow topped out at $1.1 million in Q3 2022 and bottomed at -$1.2 million in Q2 2021.
  • Average Free Cash Flow over 5 years is $115146.0, with a median of $241221.0 recorded in 2022.
  • The sharpest move saw Free Cash Flow tumbled 179.32% in 2024, then surged 455.41% in 2025.
  • Year by year, Free Cash Flow stood at $966587.0 in 2021, then crashed by 74.35% to $247954.0 in 2022, then increased by 25.03% to $310016.0 in 2023, then plummeted by 125.35% to -$78590.0 in 2024, then soared by 455.41% to $279316.0 in 2025.
  • Business Quant data shows Free Cash Flow for PBSV at $279316.0 in Q4 2025, $234488.0 in Q3 2025, and -$305848.0 in Q2 2025.